Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-AMHR2 (18-149) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
AMHR2 |
Gene ID: |
269 |
Uniprot ID: |
AMHR2_HUMAN |
Immunogen Region: |
18-149 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 18-149 of human AMHR2 (NP_065434.1). |
Immunogen Sequence: |
PPNRRTCVFFEAPGVRGSTK TLGELLDTGTELPRAIRCLY SRCCFGIWNLTQDRAQVEMQ GCRDSDEPGCESLHCDPSPR AHPSPGSTLFTCSCGTDFCN ANYSHLPPPGSPGTPGSQGP QAAPGESIWMAL |
Function | On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone. |
Protein Name | Anti-Muellerian Hormone Type-2 ReceptorAnti-Muellerian Hormone Type Ii ReceptorAmh Type Ii ReceptorMis Type Ii ReceptorMisriiMrii |
Database Links | Reactome: R-HSA-201451 |
Cellular Localisation | MembraneSingle-Pass Type I Membrane Protein |
Alternative Antibody Names | Anti-Anti-Muellerian Hormone Type-2 Receptor antibodyAnti-Anti-Muellerian Hormone Type Ii Receptor antibodyAnti-Amh Type Ii Receptor antibodyAnti-Mis Type Ii Receptor antibodyAnti-Misrii antibodyAnti-Mrii antibodyAnti-AMHR2 antibodyAnti-AMHR antibodyAnti-MISR2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance